The name of the drug is Recombinant Human Granulocyte Colony Stimulating Factor for Injection, which may cause low back pain and other pain after administration, and non-narcotic analgesics and other pain relievers may be used as appropriate.
Recombinant human granulocyte colony-stimulating factor for injection is mainly used to promote the increase of neutrophil count in bone marrow transplantation; to prevent and control neutropenia caused by chemotherapeutic drugs; to treat myelodysplastic syndromes, aplastic anemia neutropenia.
Also treats neutropenia secondary to immunosuppressive therapy; treats primary, congenital neutropenia.
Pain such as back pain, headache, lumbago, bone pain, and chest pain may occur with the use of this product and may be appropriately treated with non-narcotic analgesics, including salicylic acid drugs such as aspirin, anilines such as finasteride, arylpropionates such as ibuprofen, pyrazolones such as anakinrazole, and cyclooxygenase inhibitors such as nimesulide.
Adverse reactions to the use of this product include fever, rash, pyrexia, and thrombocytopenia, in addition to pain. It is contraindicated in patients who are allergic to the product, in patients with severe hepatic, renal, cardiorespiratory dysfunction, in myeloid leukemia patients whose naïve cells in the bone marrow have not been sufficiently reduced, and in myeloid leukemia patients with naïve cells in the peripheral blood.
It is recommended that patients go to regular hospitals in time when they feel unwell, and follow the doctor’s instructions to receive standardized medication.